MELBOURNE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Mark your calendars for an unmissable event! We are thrilled to announce our partnership with the upcoming Modern DevOps Melbourne, taking place on October 8, 2024, at the prestigious Grand Hyatt Melbourne. This event promises to be a cornerstone for industry leaders and innovators in the DevOps community. Join us at Corinium’s Modern DevOps Melbourne …
Experience Eternal Romance with Exquisite Blue Diamonds
SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 stunning new additions to its exclusive “Lovers” collection. Originally launched in 2023, this exquisite wedding ring collection now embraces new designs that seamlessly blend timeless elegance with contemporary flair. ALUXE has upheld a customer-centric approach, providing each customer with the …
中國生物製藥（1177.HK）公佈2024中期業績
重點成果 – 期內，集團共有4個創新產品獲中國國家藥品監督管理局（「NMPA」）批准上市，分別為安得衛（貝莫蘇拜單抗注射液）、安柏尼（富馬酸安奈克替尼膠囊）、安洛晴（枸櫞酸依奉阿克膠囊）和貝樂林（利拉魯肽注射液），其中3個為國家1類創新藥。 – 2024年上半年，集團創新產品收入達到61.3億元…
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
Development Highlights – During the reporting Period, four of the Group’s innovative products were approved for marketing by the National Medical Products Administration of China (“NMPA”), namely Andewei (Benmelstobart Injection), Anboni (Unecritinib capsules), Anluoqing (Envonalkib capsules) and Beilelin (Liraglutide Injection), three of which are national category 1 innovative drugs. – In the first half of 2024, the Group’s revenue from innovative products reached RMB 6.13 …